FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/12/029781 [Registered on: 14/12/2020] Trial Registered Prospectively
Last Modified On: 11/12/2020
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Preventive 
Study Design  Other 
Public Title of Study   The study of triphala ghrita and go ghrita local application in cases of fissure in ano  
Scientific Title of Study   The comparitive study between local application of go ghrita and triphala ghrita in parikartika(fissure in ano)-A randomised controlled trial 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sanjay Chandrakant Babar 
Designation  PhD Scholar 
Affiliation  Dr.D. Y. Patil College Of Ayurved and Research Centre Pune 
Address  opd no 3 deparment of shalyatantra 3 rd floor Dr D Y Patil college of ayurved and research centre pimpri sant tukaram nagar pune 411018

Pune
MAHARASHTRA
411018
India 
Phone  9011035602  
Fax    
Email  sanjaybabar14@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sanjay C Babar 
Designation  Professor 
Affiliation  Dr D Y Patil deemed to be University ,Pune-18 
Address  Dr D Y Patil college of ayurved and research centre opd no 3 deparment of shalyatantra 3 rd floor pimpri sant tukaram nagar pune 411018

Pune
MAHARASHTRA
411018
India 
Phone  9011035602  
Fax    
Email  sanjaybabar14@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sanjay Chandrakant Babar 
Designation  PhD Scholar 
Affiliation  dr d y patil college of ayurved and research centre 
Address  Dr D Y Patil college of ayurved and research centre opd no 3 deparment of shalyatantra pimpri sant tukaram nagar pune 411018
Dr D Y Patil college of ayurved and research centre opd no 3 deparment of shalyatantra pimpri sant tukaram nagar pune 411018
Pune
MAHARASHTRA
411018
India 
Phone  9011035602  
Fax    
Email  sanjaybabar14@gmail.com  
 
Source of Monetary or Material Support  
Dr D Y Patil college of ayurved and research centre pimpri pune 411018 
 
Primary Sponsor  
Name  Dr sanjay Chandrakant Babar 
Address  opd no 3 department of shalyatantra 3rd floor Dr D Y Patil college of ayurved and research centre pimpri pune 411018 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sanjay Chandrakant Babar  Dr D Y Patil college of ayurved and research centre pimpri pune  shalyatantra opd no 3 department of shalyatantra pimpri sant tukaram nagar pune 411018
Pune
MAHARASHTRA 
9011035602

drsanjaybabar14@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Dr.D.Y.Patil College Of Ayurved and Research Centre, Pimpri, Pune   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K929||Disease of digestive system, unspecified, (2) ICD-10 Condition:K929||Disease of digestive system, unspecified. Ayurveda Condition: PARIKARTIKA,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  local application of Go ghrita   drug - go ghrita route of administration - local application disease- parikartika (fissure in ano) dose- 2 ml frequency- at night only duration - for 15 days Follow up 0,5th , 10th,15th  
Intervention  local application of triphala ghrita  drug - Triphala ghrita route of administration - local application disease- parikartika (fissure in ano) dose- 2 ml frequency- at night only duration - for 15 days Follow up 0,5th , 10th,15th  
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  patients having classical features of fissure in ano namely pain in anal region during and after defecation per rectal bleeding , cutting / burning pain , longitudnal ulcer in the anal region will be selected.
Acute solitary fissures will be included .
Patient suffering from parikartika as per ayurvedic classics will be selected 
 
ExclusionCriteria 
Details  Patients suffering from any other rectal diseases.
Patient suffering from systemic disoders like HTN , DM etc
Patients on anticoagulant drugs
Patients suffering from infectious diseases like kochs  
 
Method of Generating Random Sequence   Other 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Compare the results of triphala ghrita application over plain ghrita application  follow up 0 , 5th , 10th and 15th day 
 
Secondary Outcome  
Outcome  TimePoints 
standardisation of triphala ghrita and plain Go-ghrita  follow up 0 , 5th , 10th , 15th day 
 
Target Sample Size   Total Sample Size="200"
Sample Size from India="200" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   14/12/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   Aim of the study to give ayurvedic treatment . The patient who are suffuring from diasease acute fissure in ano for not only improve the condition but also protect from recurrence of the disease along with this we can give safe , cheap and side effect free management in the form of ghrita kalpana . The trial will be conducted over 100 patients of each group for 15 days and conclusion will be  drawn from collected data. 
Close